Comparison AIM ImmunoTech (AIM) with Competitors
AIM ImmunoTech (AIM) industry is Biotechnology.
Operating Margin
AIM-10118.00%
Industry-2055.25%
Upside-8062.75%
Debt-to-Equity
AIM215.25%
Industry28.27%
Upside+661.44%
Free Cash Flow Yield
AIM-99.54%
Industry-1.75%
Upside-97.80%
P/E
AIM-0.56
Industry-20.52
Upside+1996.05%
Forward P/E
AIM2.01
Industry16.33
Upside-87.67%
P/S
AIM112.05
Industry10.01
Upside+1018.99%
P/B
AIM4.82
Industry5.15
Upside-6.37%